A08502 - Requires health insurance policies and medicaid to cover biomarker precision medical testing for diagnosis, treatment, or appropriate management of, or ongoing monitoring to guide treatment decisions for, a covered person's disease or condition when the test has recognized efficacy and appropriateness for such purposes.
New York - 2023-2024 General Assembly
Introduced byPamela J. Hunter, Aileen M. Gunther, Angelo L. Santabarbara
Last updated 8 months ago
3 Co-Sponsors
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.